Chinese biotech firm Arctic Vision has raised $32 million in a Series A round of financing led by Morningside Ventures, while Shanghai Topgen Pharmaceuticals has closed 120 million yuan ($17 million) in a Series C funding round.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
